Pregnancy-Associated Plasma Protein-A (PAPP-A) is a zinc-binding metalloproteinase protein produced by placental syncytio-trophoblasts and secreted into the maternal circulation where its concentration progressively increases until term. In recent years, PAPP-A has been studied for its potential involvement in cardiovascular (CV) disease. However, all those studies did not provide a clear view to identify the pathophysiological links between PAPP-A plasma levels and the occurrence of CV events. In this review, starting from a complete description of PAPP-A structure and biology, we present an updated overview of experimental as well as clinical evidence on the role of this metalloproteinase in CV disease. Finally, we discuss possible therapeutic approaches to antagonize its potential detrimental CV effects.

Pregnancy-Associated Plasma Protein-A and its Role in Cardiovascular Disease. Biology, experimental/clinical evidences and potential therapeutic approaches / Ziviello, Francesca; Conte, Stefano; Cimmino, Giovanni; Sasso, Ferdinando Carlo; Trimarco, Bruno; Cirillo, Plinio. - In: CURRENT VASCULAR PHARMACOLOGY. - ISSN 1570-1611. - 15:3(2017), pp. 197-206. [10.2174/1570161114666161230112126]

Pregnancy-Associated Plasma Protein-A and its Role in Cardiovascular Disease. Biology, experimental/clinical evidences and potential therapeutic approaches

ZIVIELLO, FRANCESCA;TRIMARCO, BRUNO;CIRILLO, PLINIO
2017

Abstract

Pregnancy-Associated Plasma Protein-A (PAPP-A) is a zinc-binding metalloproteinase protein produced by placental syncytio-trophoblasts and secreted into the maternal circulation where its concentration progressively increases until term. In recent years, PAPP-A has been studied for its potential involvement in cardiovascular (CV) disease. However, all those studies did not provide a clear view to identify the pathophysiological links between PAPP-A plasma levels and the occurrence of CV events. In this review, starting from a complete description of PAPP-A structure and biology, we present an updated overview of experimental as well as clinical evidence on the role of this metalloproteinase in CV disease. Finally, we discuss possible therapeutic approaches to antagonize its potential detrimental CV effects.
2017
Pregnancy-Associated Plasma Protein-A and its Role in Cardiovascular Disease. Biology, experimental/clinical evidences and potential therapeutic approaches / Ziviello, Francesca; Conte, Stefano; Cimmino, Giovanni; Sasso, Ferdinando Carlo; Trimarco, Bruno; Cirillo, Plinio. - In: CURRENT VASCULAR PHARMACOLOGY. - ISSN 1570-1611. - 15:3(2017), pp. 197-206. [10.2174/1570161114666161230112126]
File in questo prodotto:
File Dimensione Formato  
CVP PAPP-A full volume 2017.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Accesso privato/ristretto
Dimensione 5.6 MB
Formato Adobe PDF
5.6 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/669824
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact